APPLICATION OF IZOF MODEL FOR ANXIETY AND SELF-EFFICACY IN VOLLEYBALL ATHLETES: A CASE STUDY

Nogueira, Francine Caetano de Andrade; Bara, Maurício Gattás; Lourenço, Lelio Moura

doi:10.1590/1517-869220192504211038

Acessibilidade / Reportar erro

Brasil

Revista Brasileira de Medicina do Esporte

Español English

Brasil

Español English

sumário « anterior atual seguinte »

Sumário

Original Articles, PSYCHOLOGY • Rev Bras Med Esporte 25 (4) • Jul-Aug 2019 • https://doi.org/10.1590/1517-869220192504211038 copy

APPLICATION OF IZOF MODEL FOR ANXIETY AND SELF-EFFICACY IN VOLLEYBALL ATHLETES: A CASE STUDY

APLICAÇÃO DO MODELO IZOF PARA ANSIEDADE E AUTOEFICÁCIA EM ATLETAS DE VOLEIBOL: UM ESTUDO DE CASO

APLICACIÓN DEL MODELO IZOF A LA ANSIEDAD Y AUTOEFICACIA EN ATLETAS DE VOLEIBOL: UN ESTUDIO DE CASO

Authorship SCIMAGO INSTITUTIONS RANKINGS

ABSTRACT

Introduction:

The relation between psychological variables and their influence on athletic performance have been considered a crucial differential at important time points of the season.

Objectives:

This study aimed to examine the validity of the IZOF model from a multidimensional perspective of anxiety, and to investigate the possibility of extending the IZOF theory to the self-efficacy construct.

Methods:

Seven male professional volleyball players participated in the study. The Individual Self-Efficacy Scale for Volleyball and the Competitive State Anxiety Inventory – 2 reduced version were answered by the players before all matches throughout a season. At the end of each match, athletic performance was obtained through the Data Volley program.

Results:

The results showed the IZOF of self-efficacy and of each subscale of anxiety for the professional team athletes who participated in more than 10 matches during the season. The athletes showed significant variability in scores, ranging from 3 to 5 points for cognitive anxiety, 2 to 7 points for somatic anxiety, 2 to 14 points for self-confidence, and 12 to 54 points for self-efficacy. The findings also indicated that IZOFs are different in an intra- and inter-individual way. We also observed that the number of matches, in percentages across all zones (below, in, and above the IZOF), indicated that Middle Blocker 1 and Opposite 1 presented the best profiles among the 7 players analyzed, as all their variables are in the IZOF zone in the majority of matches, a fact that represents a desired profile for these athletes.

Conclusion:

Through the analysis of the data, we can attest to the applicability of the IZOF theory for professional volleyball athletes from the multidimensional perspective of anxiety and the possibility of extending the theory to the self-efficacy construct in an attempt to predict the performance of volleyball athletes from this variable. Level of evidence IV; Case series.

Keywords:
Performance Anxiety; Self Efficacy; Volleyball; Psychology, sport; Athletes

Performance/Function	Equal to/below the mean				Above the mean
	SE	CogA	SomA	SC	SE	CogA	SomA	SC
S1 (n=32)	50.8±10.9	9.9±0.8	9.8±3.1	12.5±2.2	55.1±6.9	9.6±1.2	10.1±2.8	12.6±2.2
MB1 (n=27)	64.7±6.0	9.1±1.4	7.1±0.3	16.2±1.8	61.4±4.0	9.9±0.3	7.1±0.5	15.3±1.1
MB2 (n=22)	66.3±3.6	7.4±1.8	8.4±1.2	17.3±1.4	64.9±3.7	7.5±1.9	8.9±1.6	15.4±2.7
MB3 (n=14)	73.0±6.4	7.2±1.8	7.0±0.7	19.6±0.9	66.4±9.2	6.4±1.1	7.0±0.1	20.0±0.1
PH1 (n=32)	64.8±13.0	6.8±0.8	7.6±1.1	16.4±3.3	67.8±3.8	6.7±1.0	7.3±0.5	18.1±0.5
PH2 (n=25)	74.7±6.1^* * Statistically significant differences (p <0.05) from the other players.	6.8±2.1^* * Statistically significant differences (p <0.05) from the other players.	7.9±0.9^* * Statistically significant differences (p <0.05) from the other players.	18.6±1.4	79.1±1.7	5.2±0.4	7.1±0.3	19.7±0.9
O1 (n=29)	58.1±3.8	9.1±1.6	7.4±0.6	15.8±2.1	57.7±3.3	9.3±0.7	7.2±0.6	15.9±1.3

	Cognitive Anxiety				Somatic Anxiety				Self-confidence				Self-efficacy
	M	½ SD	Range	IZOF	M	½ SD	Range	IZOF	M	½ SD	Range	IZOF	M	½ SD	Range	IZOF
S1	9.8	0.5	8–13	9.3–10.3	9.6	1.3	7–14	8.3–10.9	12.5	1.4	6–20	11.1–13.9	53.4	4.5	33–72	48.9–57.9
MB1	10.0	0.6	7–11	9.4–10.6	7.1	0.2	7–9	6.9–7.4	15.4	0.8	15–20	14.6–16.2	62.1	3.0	53–80	59.1–65.1
MB2	7.7	0.9	5–10	6.8–8.6	8.7	0.6	7–11	8.1–9.3	16.5	1.1	10–20	15.4–17.6	65.4	2.0	59–71	63.4–67.4
MB3	6.2	0.7	5–11	5.5–6.9	7.0	0.1	6–8	6.9–7.1	19.6	0.4	18–20	19.2–20.0	69.2	3.1	51–80	66.1–72.3
PH1	6.7	0.4	5–8	6.3–7.1	7.3	0.3	7–10	7.0–7.6	18.0	1.4	8–20	16.6–19.4	68.8	4.5	22–76	64.3–73.3
PH2	5.8	0.7	5–11	5.1–6.5	7.3	0.3	6–10	7.0–7.6	19.5	0.6	16–20	18.9–20.1	78.4	2.1	61–80	76.3–80.5
O1	9.2	0.6	7–12	8.6–9.8	7.2	0.2	7–9	7.0–7.4	15.9	0.8	11–18	15.1–16.7	57.7	1.8	51–63	55.9–59.5

	Below the IZOF				In the IZOF				Above the IZOF
	CogA (%)	SomA (%)	SC (%)	SE (%)	CogA (%)	SomA (%)	SC (%)	SE (%)	CogA (%)	SomA (%)	SC (%)	SE (%)
S1	28.1	46.9	37.5	21.9	59.4	21.9	6.3	40.6	12.5	31.2	56.2	37.5
MB1	22.2	7.4	22.2	18.5	70.4	92.6	77.8	44.4	7.4	0	0	37.1
MB2	31.8	54.5	31.8	31.8	36.4	13.6	36.4	31.8	31.8	31.8	31.8	36.4
MB3	28.6	7.1	14.3	21.5	21.4	78.6	85.7	35.7	50	14.3	0	42.8
PH1	46.9	0	37.5	21.9	28.1	71.9	21.9	71.9	25	28.1	40.6	6.2
PH2	57.7	3.9	23.1	15.4	23.1	61.5	76.9	84.6	19.2	34.6	0	0
O1	28.1	0	15.6	21.9	40.6	81.2	50	50	31.3	18.8	34.4	28.1

Sociedade Brasileira de Medicina do Exercício e do Esporte Av. Brigadeiro Luís Antônio, 278, 6º and., 01318-901 São Paulo SP, Tel.: +55 11 3106-7544, Fax: +55 11 3106-8611 - São Paulo - SP - Brazil
E-mail: atharbme@uol.com.br

Acompanhe os números deste periódico no seu leitor de RSS

[1] Correspondence: Francine Caetano de Andrade Nogueira. Rua Barata Ribeiro, 692/703, Copacabana, Rio de Janeiro, RJ. Brazil. 22051-002. francine_andrade_@hotmail.com